PH12018500791B1 - Stable composition of vitamin c and zinc tablet - Google Patents
Stable composition of vitamin c and zinc tabletInfo
- Publication number
- PH12018500791B1 PH12018500791B1 PH12018500791A PH12018500791A PH12018500791B1 PH 12018500791 B1 PH12018500791 B1 PH 12018500791B1 PH 12018500791 A PH12018500791 A PH 12018500791A PH 12018500791 A PH12018500791 A PH 12018500791A PH 12018500791 B1 PH12018500791 B1 PH 12018500791B1
- Authority
- PH
- Philippines
- Prior art keywords
- vitamin
- stable composition
- zinc
- tablet
- zinc tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to non-effervescent swallow tablets containing vitamin C and zinc, wherein the vitamin C is present at high concentration and is stable against oxidation and formation of carbon dioxide.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/PH2015/000016 WO2017065623A1 (en) | 2015-10-16 | 2015-10-16 | Stable composition of vitamin c and zinc tablet |
Publications (2)
Publication Number | Publication Date |
---|---|
PH12018500791B1 true PH12018500791B1 (en) | 2018-10-29 |
PH12018500791A1 PH12018500791A1 (en) | 2018-10-29 |
Family
ID=58517594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12018500791A PH12018500791A1 (en) | 2015-10-16 | 2018-04-12 | Stable composition of vitamin c and zinc tablet |
Country Status (8)
Country | Link |
---|---|
KR (1) | KR102089721B1 (en) |
CN (1) | CN108347990A (en) |
BR (1) | BR112018007634A2 (en) |
HK (1) | HK1257130A1 (en) |
MY (1) | MY191729A (en) |
PH (1) | PH12018500791A1 (en) |
TW (1) | TW201716063A (en) |
WO (1) | WO2017065623A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114469883A (en) * | 2020-10-27 | 2022-05-13 | 河北科星药业有限公司 | Aminobutyric acid and vitamin C tablet for treating piglet scurvy, preparation method and application |
WO2023031946A1 (en) * | 2021-09-01 | 2023-03-09 | Kusum Healthcare Pvt. Ltd. | Effervescent pharmaceutical composition of ascorbic acid and zinc |
CN114306269A (en) * | 2021-12-27 | 2022-04-12 | 西华大学 | Preparation method of lemon polypeptide effervescent tablets |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE526022T1 (en) * | 1998-04-20 | 2011-10-15 | Eisai R&D Man Co Ltd | STABILIZED COMPOSITIONS CONTAINING BENZIMIDAZOLES |
CN1266652A (en) * | 1999-03-12 | 2000-09-20 | 江苏康禾食品总厂 | Amino acid effervescent |
GB0330009D0 (en) * | 2003-12-24 | 2004-01-28 | Ferrosan As | Probiotic tablet formulations |
RU2375079C2 (en) * | 2004-03-29 | 2009-12-10 | Уайт | Polyvitaminic and mineral food additives |
CN1327838C (en) * | 2004-07-08 | 2007-07-25 | 北京科信必成医药科技发展有限公司 | Vitamin C oral disintegration tablet and its preparing method |
US8491937B2 (en) * | 2007-02-15 | 2013-07-23 | Wyeth Llc | Stability in vitamin and mineral supplements |
EP2385769A4 (en) * | 2008-12-15 | 2014-08-20 | Valeant Pharmaceuticals Luxembourg S R L | Rapidly dissolving vitamin formulation and methods of using the same |
EP2544665A4 (en) * | 2010-03-11 | 2014-01-01 | Rich Vitamins Llc | Quick dissolve nutritional powder |
CN102406623B (en) * | 2010-09-26 | 2014-08-27 | 上海星泰医药科技有限公司 | Nisoldipine controlled release tablet and preparation method thereof |
EP2654735B1 (en) * | 2010-12-22 | 2016-04-13 | Basf Se | Rapidly disintegrating, solid coated dosage form |
JP6363993B2 (en) * | 2012-04-27 | 2018-07-25 | メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung | Tablet with coating and manufacture of the tablet |
CN104382934A (en) * | 2013-08-19 | 2015-03-04 | 宣城柏维力生物工程有限公司 | Multivitamin tablet for pregnant women |
CN103751327B (en) * | 2014-01-15 | 2016-08-24 | 刘保国 | Zinc gluconate vc effervescent tablet |
CN104432060B (en) * | 2014-12-18 | 2016-10-05 | 郑州拓洋实业有限公司 | A kind of high zinc low sodium vitamin C effervescent tablet and preparation method thereof |
CN104784206B (en) * | 2015-03-16 | 2017-07-14 | 浙江圣博康药业有限公司 | A kind of Muhivitamin Formula With Minerals dispersible tablet |
CN108495621A (en) * | 2016-01-15 | 2018-09-04 | 诺维克斯科技私人有限公司 | Stablize agreeable to the taste vitamin C and zinc contains tablet composition |
-
2015
- 2015-10-16 CN CN201580083906.7A patent/CN108347990A/en active Pending
- 2015-10-16 MY MYPI2018701460A patent/MY191729A/en unknown
- 2015-10-16 KR KR1020187011070A patent/KR102089721B1/en active IP Right Grant
- 2015-10-16 BR BR112018007634A patent/BR112018007634A2/en not_active Application Discontinuation
- 2015-10-16 WO PCT/PH2015/000016 patent/WO2017065623A1/en active Application Filing
-
2016
- 2016-10-04 TW TW105132018A patent/TW201716063A/en unknown
-
2018
- 2018-04-12 PH PH12018500791A patent/PH12018500791A1/en unknown
- 2018-12-21 HK HK18116384.0A patent/HK1257130A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
MY191729A (en) | 2022-07-13 |
CN108347990A (en) | 2018-07-31 |
KR20180064420A (en) | 2018-06-14 |
WO2017065623A1 (en) | 2017-04-20 |
TW201716063A (en) | 2017-05-16 |
HK1257130A1 (en) | 2019-10-11 |
KR102089721B1 (en) | 2020-03-16 |
PH12018500791A1 (en) | 2018-10-29 |
BR112018007634A2 (en) | 2018-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502615B1 (en) | Chemical compounds | |
MY176231A (en) | Surface-reacted calcium carbonate for remineralisation and whitening of teeth | |
MX2019015744A (en) | Pharmaceutical compositions. | |
EP3242964A4 (en) | Electrochemical and photoelectrochemical oxidation of 5-hydroxymethylfurfural to 2,5-furandicarboxylic acid and 2,5-diformylfuran | |
PH12015501584A1 (en) | Chemical compounds | |
MY195343A (en) | A Novel Phtalazinone Derivatives and Manufacturing Process Thereof | |
MX2019005855A (en) | Powderous formulations. | |
AU2015299431B2 (en) | Pyrrolidinone derivatives as metAP-2 inhibitors | |
MX2017007371A (en) | Antibacterial compounds having broad spectrum of activity. | |
PH12018500791B1 (en) | Stable composition of vitamin c and zinc tablet | |
TW201613561A (en) | Composition comprising reduced coenzyme q10 | |
MX2017007377A (en) | Organic compounds. | |
PH12017501692A1 (en) | Solid forms of menaquinols | |
SG10201900648SA (en) | Tablet formulation of 2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide | |
PH12016502544A1 (en) | Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor | |
IN2014CH00840A (en) | ||
EA201890828A1 (en) | OPTIMIZED TABLET WITH HIGH DOSE OF ACTIVE COMPOUND, CONTAINING MESALAZIN | |
MX2018010387A (en) | Preparation containing esomeprazole. | |
PH12018501438A1 (en) | Stable and palatable composition of vitamin c and zinc lozenge tablets | |
MX2021006522A (en) | Adsorbates. | |
PH12017501897A1 (en) | 2-thiopyrimidinones | |
IN2014DN07191A (en) | ||
MX2016009696A (en) | Topical antibiotic formulations. | |
PH12016501647A1 (en) | Oral liquid vitamin supplements containing zinc and estabilized vitamin c with reduced astringency | |
MX2015011152A (en) | Omeprazole-sodium bicarbonate pharmaceutical composition to integrate a capsule for the treatment of heartburn related allopathies. |